Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. (Q51455335)
Jump to navigation
Jump to search
scientific article published on 2 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. |
scientific article published on 2 June 2011 |
Statements
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. (English)
1 reference
Torsten Zuberbier
1 reference
Franziska Ruëff
1 reference
Marcus Maurer
1 reference
Jörg Kleine-Tebbe
1 reference
Nicolas Hunzelmann
1 reference
Petra Staubach
1 reference
Randolf Brehler
1 reference
Matthias Bräutigam
1 reference
Thomas Bieber
1 reference
Tilo Biedermann
1 reference
Knut Schäkel
1 reference
Stefan Seyfried
1 reference
Jürgen Grabbe
1 reference
Thilo Jakob
1 reference
Andreas Jung
1 reference
Martin Mempel
1 reference
Michael Meurer
1 reference
Kristian Reich
1 reference
Christian Sieder
1 reference
Jan C Simon
1 reference
Vera Mahler
1 reference
2 June 2011
1 reference
128
1 reference
1
1 reference
202-209.e5
1 reference